(Q43946749)

28 November 2017

title

Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro (English)

1 reference

28 November 2017

0 references

1 reference

1 reference

Ming Chen

1

1 reference

28 November 2017

Bente Jensen

2

1 reference

28 November 2017

Lin Zhai

3

1 reference

28 November 2017

Hanne Colding

4

1 reference

28 November 2017

Aslaran Kharazmi

5

1 reference

28 November 2017

Jette E Kristiansen

6

1 reference

28 November 2017

Leif P Andersen

7

1 reference

28 November 2017

language of work or name

1 reference

1 March 2002

1 reference

International Journal of Antimicrobial Agents

28 November 2017

published in

1 reference

28 November 2017

volume

19

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

195-200

1 reference

Seroprevalence of immunoglobulin G, M, and A antibodies to Helicobacter pylori in an unselected Danish population

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Age-dependent increase of Campylobacter pylori antibodies in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Peptic ulcer and Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Trimipramine and other antipsychotics inhibit Campylobacter pylori in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Susceptibility of clinical isolates of campylobacter pylori to 24 antimicrobial and anti-ulcer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

The potential management of resistant infections with non-antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Characterization of the respiratory chain of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

Fumarate Reductase: A Target for Therapeutic Intervention Against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900489-7

7 January 2021

10.1016/S0924-8579(01)00489-7

Identifiers

DOI

1 reference

28 November 2017

1 reference